These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1781380)

  • 1. Basis for the chondro-osseous dysplasia associated with adenosine deaminase deficiency: selective toxicity to immature chondrocytes.
    Wortmann RL; Tekkanat KK; Veum JA; Meyer RA; Hood JO; Horton WA
    Adv Exp Med Biol; 1991; 309B():265-8. PubMed ID: 1781380
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
    Wortmann RL; Veum JA; Ryan LM; Cheung HS
    Arthritis Rheum; 1989 Aug; 32(8):1014-21. PubMed ID: 2788422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase deficiency and chondro-osseous dysplasia.
    Wortmann RL; Veum JA; Cheung HS
    Adv Exp Med Biol; 1986; 195 Pt A():81-3. PubMed ID: 3487928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
    Cederbaum SD; Kaitila I; Rimoin DL; Stiehm ER
    J Pediatr; 1976 Nov; 89(5):737-42. PubMed ID: 978320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor.
    Keil GJ; DeLander GE
    Life Sci; 1992; 51(19):PL171-6. PubMed ID: 1435056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adenosine deaminase and dATP levels in thymocyte apoptosis.
    Cohen A; Zhu W; Benveniste P
    Adv Exp Med Biol; 1998; 431():409-15. PubMed ID: 9598101
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine deaminase impairment and ribonucleotide reductase in human cells.
    Elford HL; Lin AL
    Ann N Y Acad Sci; 1985; 451():98-112. PubMed ID: 3907454
    [No Abstract]   [Full Text] [Related]  

  • 9. Insights into adenosine deaminase deficiency provided by murine fetal thymic organ culture with 2'-deoxycoformycin.
    Resta R; Jiang H; Hooker SW; Laurent AB; Thompson LF
    Adv Exp Med Biol; 1998; 431():451-4. PubMed ID: 9598109
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of treatment with 3'-deoxyadenosine associated deoxycoformycin on hematological parameters and activity of adenosine deaminase in infected mice with Trypanosoma evansi.
    Dalla Rosa L; Da Silva AS; Ruchel JB; Gressler LT; Oliveira CB; França RT; Lopes ST; Leal DB; Monteiro SG
    Exp Parasitol; 2013 Oct; 135(2):357-62. PubMed ID: 23933282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte-specific enzymes: a promising approach for selective immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1287-9. PubMed ID: 3274319
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation.
    Buc HA; Moncion A; Hamet M; Houllier AM; Thuilier L; Perignon JL
    Eur J Immunol; 1990 Mar; 20(3):611-5. PubMed ID: 2156710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.
    Ratech H; Greco MA; Gallo G; Rimoin DL; Kamino H; Hirschhorn R
    Am J Pathol; 1985 Jul; 120(1):157-69. PubMed ID: 4014441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency.
    Benveniste P; Cohen A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8373-7. PubMed ID: 7667298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells.
    Koller CA; Orringer EP; Berkowitz LR; Mulhern AT
    Prog Clin Biol Res; 1984; 165():227-39. PubMed ID: 6334314
    [No Abstract]   [Full Text] [Related]  

  • 19. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
    Chan TS
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
    Coleman MS; Danton MJ; Philips A
    Ann N Y Acad Sci; 1985; 451():54-65. PubMed ID: 3878121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.